91Ö±²¥

• Rheumatoid arthritis – adlimumab, etanercept, infliximab, certolizumab pegol, golumumab, abatacept and tocilizumab [in progress, ID537]

• TA247 Tocilizumab for the treatment of rheumatoid arthritis (rapid review of TA198) (February 2012)

• TA198 Tocilizumab for the treatment of rheumatoid arthritis (August 2010) replaced by TA247

• Rheumatoid arthritis – adlimumab, etanercept and infliximab (sequential use) (suspended)

• TA130 Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis (October 2007)

---

Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab, Abatacept and Tocilizumab

NICE appraisal

[in progress, ID537]

DSU report

Progression of disease in people with rheumatoid arthritis treated with non biologic therapies (PDF, 1.3MB) (February 2015)

Access , including the DSU’s response to comments on the above report.

---

Tocilizumab (rapid review)

NICE appraisal

(February 2012)

DSU report

Tocilizumab for the treatment of rheumatoic arthritis (PDF, 230KB) (September 2011)

---

Tocilizumab

NICE appraisal

TA198 Tocilizumab for the treatment of rheumatoid arthritis (August 2010) replaced by TA247

DSU report

Tocilizumab for the treatment of rheumatoid arthritis (PDF, 697KB) (May 2010)

---

Adalimumab, Etanercept and Infliximab (sequential use)

NICE appraisal

Rheumatoid arthritis – adalimumab, etanercept and infliximab (sequential use) (suspended)

DSU report

Sequential TNF-a inhibitors and non biologic DMARDs – analysis of the national databank for rheumatic diseases (PDF, 171KB) (March 2008)

The sequential use of TNF-a inhibitors – update to a report by the decision support unit (PDF, 395KB) (January 2008)

The effectiveness of non biologic DMARDs after anti TNF-a inhibitor failure (PDF, 205KB) (January 2008)

Related publication

S Lloyd, S Bujkiewicz, A Wailoo, A Sutton, D Scott. . Rheumatology 2010; Vol 49 (12): 2313-2321.

---

Adalimumab, Etanercept and Infliximab

NICE appraisal

(October 2007)

DSU report

Sequential use of TNF-a inhibitors for the treatment of rheumatoid arthritis (PDF, 213KB) (August 2006)